N Andrew Schiff
Affiliations
- at Monte Rosa Therapeutics Inc. (GLUE), 2024-06-13
- at Aclaris Therapeutics Inc. (ACRS), 2024-06-10
- Large Shareholder at Elevation Oncology Inc. (ELEV), 2023-06-21
- Large Shareholder at Zosano Pharma Corp (ZSAN), 2019-12-06
- Large Shareholder at Sunesis Pharmaceuticals Inc (SNSS), 2019-07-15
- Large Shareholder at Loxo Oncology Inc. (LOXO), 2018-07-12
- Large Shareholder, Director at Zeltiq Aesthetics Inc (ZLTQ), 2017-05-01
- Large Shareholder at Syros Pharmaceuticals Inc. (SYRS), 2016-07-06
- Large Shareholder at Agile Therapeutics Inc (AGRX), 2016-06-03
- Large Shareholder at Viewray Inc. (VRAY), 2016-03-30
- Other at Transenterix Inc. (TRXC), 2016-02-05
- Large Shareholder at T2 Biosystems Inc. (TTOO), 2015-12-09
- Large Shareholder at Esperion Therapeutics Inc. (ESPR), 2015-04-27
- Large Shareholder at Cidara Therapeutics Inc. (CDTX), 2015-04-15
- Large Shareholder at Versartis Inc. (VSAR), 2015-01-29
- Large Shareholder at Durata Therapeutics Inc. (DRTX), 2014-05-22
- Large Shareholder at Adma Biologics Inc. (ADMA), 2013-10-23
- Large Shareholder at Cempra Inc. (CEMP), 2012-02-09
Insider Trading: Purchases See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| ACRS | $23.02 | 108,601 | Director | 634,455 | 2017-08-16 | Filing | |
| AGRX | $6.00 | 1,333,333 | Large Shareholder, Director | 2,171,831 | 2014-05-23 | Filing | |
| ZLTQ | $13.00 | 769,231 | Large Shareholder, Director | 4,172,742 | 2011-10-24 | Filing |
Insider Trading: Sales See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| ACRS | $17.08 | 1,371 | Director | 434,455 | 2022-11-14 | Filing | |
| ACRS | $17.06 | 41,160 | Director | 435,826 | 2022-11-11 | Filing | |
| ACRS | $17.02 | 11,395 | Director | 476,986 | 2022-11-10 | Filing | |
| ACRS | $17.01 | 14,540 | Director | 488,381 | 2022-10-26 | Filing | |
| ACRS | $17.02 | 12,018 | Director | 502,921 | 2022-10-25 | Filing |